UHilllgene Biopharma uwine i- "2022 China Biomedicine Imboni Chain Innovation Innovation" I-Enterprises Entsha Ekhathazeke Kakhulu I-Golden Horse Award

NgoDisemba 30, 2022, "2022 China Biopharmaceutical Innovation Innovation Innoval Uhlu" kumenyezelwe ngokusemthethweni emcimbini wokuvula wefomu "lesibili le-China biopharmaceutical imboni yokuvuselela nengqungquthela yenguquko." UJiangsu Hillgene Biopharmaceutical Co, Ltd uvikele ngempumelelo "umklomelo wehhashi legolide" futhi waqashelwa ngokuthi "ubuke amabhizinisi aqhamuke kakhulu angu-2022."

Lolu hlu luhlanganiswe kusetshenziswa idatha kusuka emithonjeni ehlukahlukene, kufaka phakathi uhlelo olusha lokucwaninga ngezidakamizwa kanye ne-database yokuqapha izidakamizwa, imininingwane ebanzi yezidakamizwa, kanye nemininingwane yokufuduka kwezidakamizwa. Iphrojekthi ye- "Marous New Drug Cration" ekhethekile ", izindlela zokuhlola zasungulwa ngezindlela eziyi-12, njengezinhloso zonoveli, intuthuko yezobuchwepheshe, izidingo zemitholampilo, kanye nokutshalwa kwemali. Iphaneli yabafundi basezemfundo kanye nochwepheshe benze izingqungquthela zevidiyo, ukuvota online, futhi banesisindo sokuhlola okuphelele ukukhetha ama-Benchmark Awards, ama-Kunpeng Awards, kanye nemiklomelo yeGold Horses. Lolu hlu lube ngumklomelo ovelele emkhakheni wezinto ezintsha kanye noguquko embonini ye-biopharmaceutical.

Njengoba inkampani yokuqala ezweni izonikezwa "imvume yokukhiqiza izidakamizwa" ngokugcwele - Inqubo ephathisiwe yemoto - I-T Cell Clears izidakamizwa, amaseli eHillene anikezelwe ekuthuthukiseni ukuthuthukiswa kwenkontileka kanye ne-gene Therapy Services.

Lo mklomelo awusho nje ukunakekelwa kwe-Hilllgene billgene Esikhathini esizayo, uHillgene Biopharma uzoqhubeka nokuhlose ukusetha amazinga ezimboni, ukulungiselela amamodeli wesevisi, ukusheshisa ukuthuthukiswa kwezidakamizwa zokwelapha amaseli, futhi kusunduzele okuningi kwalezi zindlela ezintsha ezibonakalayo emakethe.

Isikhathi Seposi: 2023 - 02 - 17 00:00:00:00